Cellosaurus logo
expasy logo

Cellosaurus RH9 (CVCL_U264)

[Text version]
Cell line name RH9
Accession CVCL_U264
Resource Identification Initiative To cite this cell line use: RH9 (RRID:CVCL_U264)
Comments Group: Patented cell line.
Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12043.
Population: Caucasian.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Cell type: T-cell; CL=CL_0000084.
Sequence variations
  • Gene deletion; HGNC; 7208; MPDZ; Zygosity=Homozygous (from parent cell line).
  • Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
Disease Sezary syndrome (NCIt: C3366)
Sezary syndrome (ORDO: Orphanet_3162)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1240 (H9)
Children:
CVCL_U265 (RH9/CB)
Sex of cell Male
Age at sampling 53Y
Category Cancer cell line
Publications

Patent=US5580772
Garry R.F. Jr.
Association between a novel human intracisternal A-type retroviral particle-type II (HIAP-II) and idiopathic CD4+ T-lymphocytopenia (ICL).
Patent number US5580772, 03-Dec-1996

Cross-references
Cell line databases/resources cancercelllines; CVCL_U264
Encyclopedic resources Wikidata; Q54950372
Entry history
Entry creation03-Feb-2014
Last entry update05-Oct-2023
Version number16